Skip to content

Multi-center clinical effect observation of Xiaozhi tea combined with acupuncture at Back-shu point in the treatment of obesity with liver stagnation and spleen deficiency

Multi-center clinical effect observation of Xiaozhi tea combined with acupuncture at Back-shu point in the treatment of obesity with liver stagnation and spleen deficiency

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001817
Enrollment
Unknown
Registered
2025-09-24
Start date
2025-10-13
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Control group:Placebo combined with sham acupuncture
Traditional Chinese Medicine Group:Xiaozhi tea combined with sham acupuncture
Acupuncture group:Placebo combined with acupuncture
Combined group:Xiaozhi tea combined with acupuncture

Sponsors

Nanchang Hongdu Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-60 years old, gender not limited; 2.BMI=24.0kg/m ², or waist circumference: =90cm for men and = 85cm for women; 3. Voluntarily participate in the research and sign the informed consent form; 4. No history of major acute or chronic diseases (diabetes, coronary heart disease, stroke, cancer); 5. Physical Constitution assessment: Liver depression and spleen deficiency (formulated based on the investigation of liver depression and spleen deficiency types, spleen deficiency types and clinical syndromes in accordance with the Guidelines for Clinical Research of New Traditional Chinese Medicine Drugs (Trial). Main symptoms: Fatigue and weakness, drowsiness, which cannot be relieved by rest. Secondary symptoms: Depression or irritability, quick to breathe, pale tongue with tooth marks on the edges, thin white coating on the tongue, and deep and fine pulse. 6. No other weight loss interventions have been received in the past three months.

Exclusion criteria

Exclusion criteria: 1.Perinatal women (pregnant and 4 weeks postpartum) and lactating women; 2. Combined with severe cardiovascular and cerebrovascular diseases, severe liver and kidney diseases; 3. Obesity is caused by thyroid diseases (hypothyroidism), hypothalamic-pituitary diseases, Cushing's syndrome and other diseases; 4. Those who are allergic to traditional Chinese medicine or acupuncture intervention; 5. Recently taken medications that affect weight; 6. Patients with severe primary diseases such as malignant tumors and liver cirrhosis, secondary cardiovascular and cerebrovascular events such as coronary heart disease and stroke, and those with mental disorders or poor compliance.

Design outcomes

Primary

MeasureTime frame
Weight;BMI;

Secondary

MeasureTime frame
Waist circumference/Hip circumference;Percentage of body fat;Health Index Scale (EQ-5D) scale;Food Frequency Method Questionnaire Survey (FFQ;Abdominal ultrasound;

Countries

China

Contacts

Public ContactWangYing

Nanchang Hongdu Hospital of Traditional Chinese Medicine

314670987@qq.com15867056872

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026